Med Life SA (M.RO) stock: key figures, P/E, revenue and dividend

Health Care · Romania · ISIN ROMEDLACNOR6

Price
11.00 RON
Market cap
5.84 bn RON
P/E (2024)
–
P/S (2024)
2.15
Dividend yield
0.00 %
Net margin
0.94 %
Return on equity (ROE)
5.04 %
Return on assets (ROA)
0.85 %

Med Life SA financials

Fiscal year20232024
Revenue2.21 bn RON2.72 bn RON
Gross profit1.28 bn RON1.57 bn RON
Operating income94.21 m RON151.61 m RON
EBIT80.61 m RON138.29 m RON
Net income3.68 m RON25.55 m RON

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Med Life SA

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.